- Home
- » Tags
- » Rupintrivir
Top View
- Targeting the SARS-Cov-2 Main Protease to Repurpose Drugs for COVID-19
- Feline Coronavirus Drug Inhibits the Main Protease of SARS-Cov-2 and Blocks Virus Replication
- A Simplified Cell-Based Assay to Identify Coronavirus 3CL Protease Inhibitors
- Boceprevir, GC-376, and Calpain Inhibitors II, XII Inhibit SARS-Cov-2 Viral Replication by Targeting the Viral Main Protease
- A Nanoluciferase SARS-Cov-2 for Rapid Neutralization Testing and Screening of Anti-Infective Drugs for COVID-19 ✉ Xuping Xie 1,8 , Antonio E
- Programand ABSTRACTS
- Targeting SARS‐Cov‐2 Viral Proteases As A
- Rational Design of a New Class of Protease Inhibitors for the Potential Treatment of Coronavirus Diseases
- Like Cysteine Protease Inhibitors Using a Multiplex Screening Platform Koen Vandyck1, Jerome Deval2, Dorothée Bardiot5, Leonid Beigelman1,2, Lawrence M
- Bepridil Is Potent Against SARS-Cov-2 in Vitro